[Psychosomatic aspects of hepatic insufficiency; therapeutic possibilities of drugs with central action (meprobamate, benactyzine, chlorpromazine) and with central and peripheral action (glucose-1-phosphate)].
D001535:Benactyzine; D002746:Chlorpromazine; D005958:Glucosephosphates; D048550:Hepatic Insufficiency; D006600:Hexosephosphates / Q000627:therapeutic use*; D006801:Humans; D008107:Liver Diseases; D008620:Meprobamate; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D005958:Glucosephosphates; D006600:Hexosephosphates; D014149:Tranquilizing Agents; D001535:Benactyzine; D008620:Meprobamate; C031590:glucose-1-phosphate; D002746:Chlorpromazine
HEXOSEPHOSPHATES/therapeutic use; LIVER DISEASES; TRANQUILIZING AGENTS/therapeutic use
Psicosomatica della insufficienza epatica; possibilità terapeutiche con farmaci ad azione centrale (meprobamati, benactizine, cloropromazine) e ad azione centrale e periferica (glucosio-1-fosfato).